Dr. Ericsson attended both Uppsala and Stockholm University and obtained his PhD from Stockholm University in 1992. He then moved to the University of California-Los Angeles (UCLA), where he worked on the transcriptional regulation of cholesterol metabolism. 

Dr. Ericsson established his own independent research group in 1998 at the Ludwig Institute for Cancer Research, focusing on the post-translational regulation of a family of transcription factors critical for cholesterol and lipid metabolism, i.e. the SREBP family of proteins. In 2009, Dr. Ericsson became an SFI Stokes Professor at University College Dublin, where his group continued their work on the transcriptional and post-translational regulation of lipid metabolism. Dr. Ericsson has been an Associate Professor at HBKU since May 2019.

Mourad Ouzzani is the Research Director of the Research Engineering Group whose mission is to productize QCRI's research. The group has produced several products some of which have been commercialized through different channels. These include SIHA, a system for integrated health analytics, QARTA, an AI-enabled map engine, Zaman, a smart bilingual news app for the Arab world, SAQR a social media analytics platform with a focus on Arabic, Fehris, a powerful personal content management system, and NxPalin, a system for explainable, transparent, and Fair AI.

Mourad conducts research in data management and analytics with a focus on data integration, data cleaning, and more recently data-centric AI. Mourad has played a key role in establishing the data analytics group (now QCAI) within QCRI. He was the project lead of Rayyan, the leading systematic reviews web and mobile app, which is being used by more than 250K users worldwide. Rayyan has since graduated from QCRI to a startup, Rayyan Systems Inc.  Mourad’s research work has led to numerous publications in top tier venues including PVLDB, TKDE, SIGMOD, and ICDE. Mourad has been PI or CoPI in more than 15 grant proposals funded by NSF, NIH, DHS, and other funding agencies.

Abdulaziz Al-Homaid is a Software Engineer at Qatar Computing Research Institute of Hamad Bin Khalifa University. He has been working on leveraging insights from hospital health data. Specifically, he applied signal processing algorithms to detect abnormalities in electrocardiogram data during vigorous activity. He also worked on analyzing the relationship between exercise and glucose levels. He is experienced in utilizing libraries for large language models and training them on multi-GPU machines.

Ms. Dodia has been a committed member of Qatar Foundation since 2012. She's been actively involved with several research groups in QCRI since 2014, currently serving as a full-time researcher for the cybersecurity group. 

Her vision is to serve Qatar and fuel the country's cybersecurity intelligence and R&D advancements with the knowledge and skills she's acquired over the years.

Dr. Saif Al-Kuwari is an associate professor at the College of Science and Engineering and director of the Qatar Center for Quantum Computing (QC2) at Hamad Bin Khalifa University. Dr. Saif Al-Kuwari graduated in computers and networks from the University of Essex and has two PhDs in Cryptography and Computational Forensics from the University of Bath and Royal Holloway, University of London

He is a fellow of IET and BCS and a senior member of IEEE and ACM. His research focuses on quantum cryptography, quantum machine learning, and quantum sensing.

Dr. Mingzhan Xue obtained his Medical degree (Bachelor of Medicine), Master’s degree in Medical Genetics, and PhD in Medicine from the School of Medicine of Xi’an Jiaotong University (known as the Xi’an Medical University before 2000) in China. Between 1984 and 1999, he was appointed Assistant Professor, Lecturer, and Associate Professor in Medical Genetics at Xi’an Medical University, China. He also undertook postdoctoral positions at the University of Lausanne in Switzerland, and Newcastle University and Queen Mary University of London in the UK. From 2006 to 2018, he worked as a research fellow at the University of Warwick in the UK.

يشغل الدكتور أحمد المقرمد منصب المدير التنفيذي لمعهد قطر لبحوث الحوسبة، عضو مؤسسة قطر. وقبل انضمامه إلى مؤسسة قطر في العام 2010، شغل عدداً من المناصب المرموقة في المجالين الأكاديمي والصناعي. كما تقلد مناصب عدة في هيئة التدريس بجامعة ولاية بنسلفانيا وجامعة بادوفا وجامعة بوردو، حيث شارك بشكل فعّال في مجالي التدريس والبحوث العلمية على مدار 22 عاماً.

اضطلع الدكتور أحمد المقرمد بتأسيس مركز سايبر في ديسكفري بارك ومركز إنديانا لنظم قواعد البيانات بجامعة بوردو وتولى إدارتهما. كما شغل منصب كبير العلماء بمكتب الاستراتيجيات والتكنولوجيا التابع لشركة هيوليت باكارد، كما عمل مستشاراً لعدد من الجهات من بينها تلكورديا تكنولوجي، وبيلكور، وآي بي إم، وسي إس سي، وهاريس، ودي أتش براون أشوشيتس، وإم سي سي، وبيل نورثرن ريسيرتش، وموليكيولار ديزاين لابس، وسوجيه (إيطاليا)، ومركز السدرة للطب والبحوث، ويوني إس كيو إل.

حصل الدكتور أحمد المقرمد في سن مبكرة على جائزة أصغر باحث من المؤسسة القومية للعلوم التي منحها له الرئيس الأمريكي رونالد ريجان. كما حاز درجة الزمالة من معهد مهندسي الكهرباء والإلكترونيات، وهو عالم بارز في جمعية الحوسبة الآلية، وحاصل على عضوية جمعية سيجما إكس آي الأمريكية لتقدم العلوم. كما اختارته كل من جامعة دايتون، وجامعة ولاية أوهايو لإدراج اسمه ضمن خريجيها المميزين. كما ترأس الدكتور المقرمد العديد من لجان البرامج ومجالس التحرير. يشمل نطاق خبرته التركيز على بحوث قواعد البيانات المؤسسية، وتلك الموجهة نحو التطبيقات.

قام الدكتور أحمد المقرمد بنشر الكثير من مؤلفاته، حيث قام بتأليف 6 كتب وأكثر من 180 ورقة بحثية، وحصل على العديد من المنح الفعالة من الشركات، والوكالات الحكومية الرسمية والفيدرالية.

نال الدكتور أحمد المقرمد شهادة البكالوريوس في علوم الحاسوب من جامعة دايتون، ودرجتي الماجستير والدكتوراه من جامعة ولاية أوهايو.

Dr Ayman Al Haj Zen is an Associate Professor at the College of Health and Life Sciences at Hamad Bin Khalifa University. He obtained his PhD from the University of Paris VII, where he studied the role of small proteoglycans in regulating vascular repair and atherosclerosis. Afterward, he moved to England and worked as a Postdoctoral Researcher at various institutions, including the London Research Institute, the University of Bristol, and the University of Oxford. During this time, he focused on studying the role of cell-cell communication signaling in ischemia-induced angiogenesis and vascular regeneration.

In 2013, Dr. Al Haj Zen received an intermediate research fellowship from the British Heart Foundation (Oxford) Centre of Research Excellence allowing him to establish his independent research program in vascular biology and drug discovery at the University of Oxford. His research centered on identifying new therapeutic targets and strategies to modulate angiogenesis and vascular response in diseases such as ischemic vascular disease, atherosclerosis, vascular dementia, and cancer.

His lab develops 3D microfluidics organ-on-chip disease models combined with high throughput quantitative image-based approaches to conduct genetic and drug screens that have applications in understanding underlying disease mechanisms and developing new therapeutics and personalized medicines.

Aisha Al-Qahtani holds a B.S. degree in electrical and computer engineering from Texas A&M University ,an M.S. degree in biological and biomedical science and  Ph.D. in biological & biomedical science from (Hamad Bin Khalifa University (HBKU).

Her research focuses on applying electrical engineering in the biomedical field; she was among the team that worked on the biosensor design in smart sensor design at HBKU. She has recently expanded her scope of research to focus more on computational biology in the Center for Artificial Intelligence at Qatar Computing Research Institute.